We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tomatoes in Diet Protect Mice from Skin Cancer

By LabMedica International staff writers
Posted on 31 Jul 2017
Cancer researchers working with a mouse model showed that a diet supplemented with tomatoes could protect against skin cancer.

Based on previous studies that had found that prolonged tomato consumption could mitigate ultraviolet (UV) light induced sunburn via unknown mechanisms, investigators at Ohio State University (Columbus, USA) hypothesized that tomato consumption would protect against skin cancer.

To test this theory, the investigators fed diets supplemented with 10% tangerine or red tomato powder to a population of SKH-1 hairless and immunocompetent mice for 35 weeks. More...
From weeks 11 to 20, the mice were exposed to UV light, three times per week, and tumors were tracked weekly. Control mice were fed the same diets but not exposed to UV light.

Results published in the July 11, 2017, online edition of the journal Scientific Reports revealed that significantly fewer tumors developed in male mice consuming red tomato diets or pooled tomato diets compared to controls. Carotenoid levels in plasma and skin were quantitated, with total lycopene higher in skin of tangerine fed animals despite a lower dose. Lycopene, the primary carotenoid in tomatoes, has been shown to be the most effective antioxidant of these pigments.

Metabolomic analyses elucidated compounds derived from tomato glycoalkaloids (including tomatidine and hydroxylated-tomatidine) as significantly different metabolites in skin after tomato supplementation.

Results showing that there were no significant differences in tumor number for female mice in the study confirmed previous findings that male mice developed tumors earlier after UV exposure and that their tumors are more numerous, larger, and more aggressive.

"This study showed us that we do need to consider sex when exploring different preventive strategies," said senior author Dr. Tatiana Oberyszyn, professor of pathology at Ohio State University. "What works in men may not always work equally well in women and vice versa."

Related Links:
Ohio State University


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.